Sertraline + Placebo
ApprovedTerminated 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Phobia, Social
Conditions
Phobia, Social, Panic Disorder, Agoraphobia, Obsessive-Compulsive Disorder, Anxiety Disorders, Major Depressive Disorder
Trial Timeline
Jul 1, 2002 → Jan 1, 2018
NCT ID
NCT00182533About Sertraline + Placebo
Sertraline + Placebo is a approved stage product being developed by Pfizer for Phobia, Social. The current trial status is terminated. This product is registered under clinical trial identifier NCT00182533. Target conditions include Phobia, Social, Panic Disorder, Agoraphobia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00406952 | Pre-clinical | Completed |
| NCT00182533 | Approved | Terminated |
| NCT01114100 | Approved | Completed |
Competing Products
4 competing products in Phobia, Social
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| LY686017 + paroxetine + placebo | Eli Lilly | Phase 2 | 52 |
| atomoxetine + placebo | Eli Lilly | Phase 2/3 | 65 |
| Quetiapine XR | AstraZeneca | Phase 2 | 52 |
| quetiapine | AstraZeneca | Approved | 85 |